Anticholinergic agents do not block light-induced circadian phase shifts

Area of Science:

• Neuroscience
• Chronobiology
• Circadian Rhythms

Background:

• Acetylcholine (ACh) is a neurotransmitter implicated in various brain functions.
• Its potential role in the circadian system, particularly in mediating responses to light (photoentrainment), has been previously suggested.

Purpose of the Study:

• To investigate whether acetylcholine is the primary mediator of circadian photoentrainment in rats.
• To determine if depleting ACh stores affects the ability of light pulses to shift circadian rhythms.

Main Methods:

• Rats were centrally infused with hemicholinium-3 (HC-3) to deplete brain acetylcholine stores.
• Subsequent light pulses were administered to assess their phase-shifting effects.
• Control experiments involved treating animals with atropine, a muscarinic receptor antagonist.

Main Results:

• Hemicholinium-3 (HC-3) administration did not prevent the circadian phase-shifting effects of light pulses.
• Rats treated with atropine also exhibited normal responses to light pulses.
• Both delay and advance phase shifts were observed, indicating no impairment in photoentrainment.

Conclusions:

• The findings do not support the hypothesis that acetylcholine is the primary mediator of photoentrainment in the rat circadian system.
• The previously reported effects of carbachol injections on circadian rhythms may be due to non-specific actions.